Company
IO Biotech
Pioneering novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines with the goal of improving outcomes for people with melanoma and other tumor types.
Also known as IO Biotech, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- IO Biotech, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines
Products
- Other
- Cylembio
Loading relationship preview